The isotretinoin, Accutane, is still being used to treat severe acne. The distribution of Accutane is strictly regulated for distribution because it is known to cause birth defects. Accutane has been banned in Europe. The FDA has implemented educational material for women of childbearing age regarding this product through a program called iPledge.
The educational material and counseling has been unsuccessful in reaching women. Those who volunteered for the iPledge program stated they received less information on how to protect themselves using various means of contraception to prevent unintended pregnancies while taking Accutane. That being said, doctors and nurses need to provide more comprehensive education and access to contraceptives for patients who are prescribed isotretinoins, especially those of childbearing age.
For more information on this topic, click on the following link:
Health News Digest. (2013). “Lack of birth control information poses danger for women on common acne drug”. Retrieved November 22, 2013, from: http://www.healthnewsdigest.com/news/Women_s_Health_260/Lack-of-Birth-Control-Information-Poses-Danger-for-Women-on-Common-Acne-Drug.shtml